Xavier T. Reveles - Jan 10, 2025 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Chief Operating Officer
Signature
/s/ Maria Zannes, as attorney-in-fact for Xavier T. Reveles
Stock symbol
BIAF
Transactions as of
Jan 10, 2025
Transactions value $
$0
Form type
4
Date filed
1/14/2025, 04:15 PM
Previous filing
Feb 2, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $0 +21.6K +106.22% $0.00 41.9K Jan 10, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares of common stock that vest pro rata on a monthly basis for 12 months commencing on February 10, 2025.